15 Dec 2017 08:36
For immediate release
15 December 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Purchase of Shares by PDMR
The Company announces that it has received notification that on 14 December 2017, John Hearle, Director and a Person Discharging Managerial Responsibilities ("PDMR") of the Company purchased 11,870 Ordinary Shares in the Company.
The following notifications, which have been made in accordance with the requirements of the EU Market Abuse Regulations, provide further detail:
1. | Details of PDMR | |||||
a) | Name | John Hearle | ||||
2. | Reason for Notification Purchase of shares | |||||
a) | Position/status | Director | ||||
b) | Initial notification/ amendment | Initial notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | MedicX Fund Limited | ||||
b) | LEI | 2138008POF35FTNFCB25 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code | Ordinary shares of no par value GG00B1DVQL92 | ||||
b) | Nature of the transaction | Purchase of 11,870 shares | ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated Information | N/A single transaction | ||||
e) | Date of the transaction | 14 December 2017
| ||||
f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
g) | Other information | Following the transaction, John Hearle holds 43,869 shares in the Company | ||||
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 152 properties.
The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers
Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.
The Company's Legal Entity Identifier is 2138008POF35FTNFCB25